NCT06099886View on ClinicalTrials.gov

Repurposing Lithium for Parkinson's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

October 12, 2023

Primary Completion Date

December 6, 2024

Study Completion Date

April 30, 2025

Conditions
Parkinson's Disease
Interventions
DIETARY_SUPPLEMENT

Lithium aspartate

Lithium aspartate 30-45mg/day

Trial Locations (1)

14221

University at Buffalo, Williamsville

All Listed Sponsors
collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

State University of New York at Buffalo

OTHER

NCT06099886 - Repurposing Lithium for Parkinson's Disease | Biotech Hunter | Biotech Hunter